Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors

Abstract excerpt

Prostate cancer is the most commonly diagnosed non-cutaneous neoplasm among American males and is the second leading cause of cancer-related death. Prostate specific antigen screening has resulted in earlier disease detection, yet approximately 30% of men will die of metastatic disease. Slow disease progression, an aging population and associated morbidity and mortality underscore the need for improved disease...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer-related molecular mechanisms research
• Share to Molecular Biology Techniques and Applications
• Share to Prostate Cancer Treatment and Research